At a glance
ClinicalIndex Comparison RecordN/ACompleted· 120 enrolled
Drug / intervention
Cetaphil® Restoraderm® moisturizer + Cetaphil® Restoraderm® body wash +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Cetaphil® Restoraderm® Moisturizer on Very Dry Skin in Children With a Controlled Atopic Dermatitis:a Randomised, Parallel Group Study
In Brief
A clinical study evaluating Cetaphil® Restoraderm® moisturizer + Cetaphil® Restoraderm® body wash and Cetaphil® Restoraderm® body wash for Atopic Dermatitis. Completed, enrolled 120 participants across 8 sites in 2 countries.
Detailed Summary
The purpose of this study is to evaluate the effect of Cetaphil® Restoraderm® skin restoring moisturizer in reducing the signs and symptoms of very dry atopic skin in young children. Subjects with atopic dermatitis (AD) in remission phase will be randomized to receive either Cetaphil® Restoraderm® skin restoring body wash only, or the same body wash in association with Cetaphil® Restoraderm® skin restoring moisturizer.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtopic Dermatitis
CountriesChina, Philippines
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartMay 2015
First PostedOct 2015
Primary CompletionFeb 2016
TodayJul 2026
First PostedOct 28, 2015
Enrollment StartMay 29, 2015
Primary CompletionFeb 3, 2016
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 10.7 years ago
Interventions
Cetaphil® Restoraderm® moisturizer + Cetaphil® Restoraderm® body washother
Cetaphil® Restoraderm® body washother